Brind.

Truist reduced its price target on DaVita, which is in Warren Buffett's investment portfolio, citing mixed short-term outlook.

1 report, 1 independent Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Truist reduced its price target on DaVita, which is in Warren Buffett's investment portfolio, citing mixed short-term outlook.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Insider MonkeyTruist Reduces PT on DaVita Inc. (DVA) from $170 to $164; Zacks Keeps ‘Hold’ Rating With a low price-to-earnings multiple and a significant presence in Warren Buffett’s investment portfolio, DaVita I